Natco Pharma Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2023	Dec-2022	Sep-2022	Jun-2022	Mar-2022
Gross Sales	897.90	492.50	432.10	884.60	596.80
Excise Duty	--	--	--	--	--
Net Sales	897.90	492.50	432.10	884.60	596.80
Other Operating Income	--	--	--	--	--
Other Income	29	20.80	20.50	34.30	13.80
Total Income	926.90	513.30	452.60	918.90	610.60
Total Expenditure	558.80	386.60	336.80	489.30	615.40
PBIDT	368.10	126.70	115.80	429.60	(4.80)
Interest	2.70	3.80	3.80	4.20	6.70
PBDT	365.40	122.90	112	425.40	(11.50)
Depreciation	41	41.50	41.70	39.60	38.10
Minority Interest Before NP	--	--	--	--	--
Tax	58.30	18.20	14.10	72.10	(0.60)
Deferred Tax	(9.70)	0.90	(0.60)	(6.70)	1.50
Reported Profit After Tax	275.80	62.30	56.80	320.40	(50.50)
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	275.80	62.30	56.80	320.40	(50.50)
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	275.80	62.30	56.80	320.40	(50.50)
EPS (Unit Curr.)	15.11	3.41	3.11	22.55	(2.77)
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	62.50	37.50	175	--
Equity	36.50	36.50	36.50	36.50	36.50
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	41.00	25.73	26.80	48.56	(0.80)
PBDTM(%)	40.70	24.95	25.92	48.09	(1.93)
PATM(%)	30.72	12.65	13.14	36.22	(8.46)

QuickLinks for Natco Pharma Ltd.